|
| Products |
|
| Human API's |
|
|
|
| Active pharmaceutical Ingredients |
: |
Ciprofloxacin Hydrochloride |
|
| Chemical Name |
: |
Ciprofloxacin hydrochloride is 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(piperazin-1- yl)quinoline-3-carboxylic acid, monohydrochloride, monohydrate. |
|
| CAS NO |
: |
86393-32-0 |
|
| Molecular Formula |
: |
C 17 H 19 ClFN 3 O 3 .H 2 O |
|
| Molecular Weight |
: |
385.82 |
|
| Pharmacopoeia Compliance |
: |
USP / IP / EP / BP |
|
| Description |
: |
Off White to Pale Yellow Crystalline powder |
|
| Shelf life |
: |
5 years |
|
|
|
|
|
|
| Active pharmaceutical Ingredients |
: |
Ciprofloxacin Base |
|
| Chemical Name |
: |
Ciprofloxacin Base is 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(piperazin-1- yl)quinoline-3-carboxylic acid. |
|
| CAS NO |
: |
85721-33-1 |
|
| Molecular Formula |
: |
C17H18FN3O3 |
|
| Molecular Weight |
: |
331.35 |
|
| Pharmacopoeia Compliance |
: |
USP / IP / EP / BP |
|
| Description |
: |
Off White to Pale Yellow Crystalline powder |
|
| Shelf life |
: |
5 years |
|
|
|
|
|
|
| Active pharmaceutical Ingredients |
: |
Ciprofloxacin Hydrochloride |
|
| Chemical Name |
: |
Ciprofloxacin hydrochloride is 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(piperazin-1- yl)quinoline-3-carboxylic acid, monohydrochloride, monohydrate. |
|
| CAS NO |
: |
86393-32-0 |
|
| Molecular Formula |
: |
C17H19ClFN3O3.H2O |
|
| Molecular Weight |
: |
385.82 |
|
| Pharmacopoeia Compliance |
: |
USP / IP / EP / BP |
|
| Description |
: |
Off White to Pale Yellow Crystalline powder |
|
| Shelf life |
: |
5 years |
|
|
|
|
|
|
| Active pharmaceutical Ingredients |
: |
Ciprofloxacin Hydrochloride |
|
| Chemical Name |
: |
Ciprofloxacin hydrochloride is 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(piperazin-1- yl)quinoline-3-carboxylic acid, monohydrochloride, monohydrate. |
|
| CAS NO |
: |
86393-32-0 |
|
| Molecular Formula |
: |
C17H19ClFN3O3.H2O |
|
| Molecular Weight |
: |
385.82 |
|
| Pharmacopoeia Compliance |
: |
USP / IP / EP / BP |
|
| Description |
: |
Off White to Pale Yellow Crystalline powder |
|
| Shelf life |
: |
5 years |
|
|
|
|
|
|
| Active pharmaceutical Ingredients |
: |
Ciprofloxacin Lactate |
|
| Chemical Name |
: |
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl) -3-quinoline carboxylic acid Lactate |
|
| CAS NO |
: |
85721-33-1 |
|
| Molecular Formula |
: |
C20H26FN3O7 |
|
| Molecular Weight |
: |
439.5 |
|
| Pharmacopoeia Compliance |
: |
Not Applicable |
|
| Description |
: |
Off White to Light Yellow crystalline powder |
|
| Shelf life |
: |
5 years |
|
|
|
|
|
|
| Active pharmaceutical Ingredients |
: |
Ofloxacin Base |
|
| Chemical Name |
: |
(±)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid. |
|
| CAS NO |
: |
82419-36-1 |
|
| Molecular Formula |
: |
C18H20FN3O4 |
|
| Molecular Weight |
: |
361.4 |
|
| Pharmacopoeia Compliance |
: |
USP / IP / EP |
|
| Description |
: |
A Pale yellow or light yellow, crystalline powder |
|
| Shelf life |
: |
5 years |
|
|
|
|
|
|
| Active pharmaceutical Ingredients |
: |
Ofloxacin Hydrochloride |
|
| Chemical Name |
: |
(±)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid mono hydrochloride. |
|
| CAS NO |
: |
118120-51-7 |
|
| Molecular Formula |
: |
C18H21FN3O4Cl |
|
| Molecular Weight |
: |
397.94 |
|
| Pharmacopoeia Compliance |
: |
Inhouse Standard |
|
| Description |
: |
White or light yellow crystalline powder |
|
| Shelf life |
: |
3 years |
|
|
|
|
|
|
| Active pharmaceutical Ingredients |
: |
Levofloxacin Hemihydrate |
|
| Chemical Name |
: |
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid,9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxohydrate(2:1),(S)- |
|
| CAS NO |
: |
100986-85-41 |
|
| Molecular Formula |
: |
C18H20FN3O4 ½ H2O |
|
| Molecular Weight |
: |
370.38 |
|
| Pharmacopoeia Compliance |
: |
Inhouse Standard |
|
| Description |
: |
Almost white to light yellow crystalline Powder |
|
| Shelf life |
: |
4 years |
|
|
|
|
|
|
| Active pharmaceutical Ingredients |
: |
Quinine Sulphate |
|
| Chemical Name |
: |
Cinchonan-9-ol,6-methoxy-(8α,9R)-,sulfate(2:1) (salt),dihydrate |
|
| CAS NO |
: |
6119-70-6 |
|
| Molecular Formula |
: |
(C20H24N2O2)2.H2SO4.2H2O |
|
| Molecular Weight |
: |
782.94 |
|
| Pharmacopoeia Compliance |
: |
USP / BP / EP / IP |
|
| Description |
: |
White, fine, needle-like crystals. |
|
| Shelf life |
: |
5 years |
|
|
|
|
| Veterinary |
|
|
|
| Active pharmaceutical Ingredients |
: |
Enrofloxacin Base |
|
| Chemical Name |
: |
1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-1,4-dihdro-4-oxoquinoline -3-carboxylic acid. |
|
| CAS NO |
: |
93106-60-6 |
|
| Molecular Formula |
: |
C19H22FN3O3 |
|
| Molecular Weight |
: |
359.39 |
|
| Pharmacopoeia Compliance |
: |
Inhouse Standard |
|
| Description |
: |
Pale yellow crystalline powder |
|
| Shelf life |
: |
5 years |
|
|
|
|
|
|
| Active pharmaceutical Ingredients |
: |
Enrofloxacin Hydrochloride |
|
| Chemical Name |
: |
1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecaboxylic acid- Hydrochloride. |
|
| CAS NO |
: |
93106-60-6 |
|
| Molecular Formula |
: |
C19H23FN3O3Cl |
|
| Molecular Weight |
: |
395.9 |
|
| Pharmacopoeia Compliance |
: |
Inhouse Standard |
|
| Description |
: |
Off white to pale yellow crystalline powder |
|
| Shelf life |
: |
5 years |
|
|
|
|
|
|
| Active pharmaceutical Ingredients |
: |
Difloxacin Hydrochloride |
|
| Chemical Name |
: |
6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-7-(4-methyl piperazin-1-yl)-4-oxoquinoline-3-carboxylic acid hydrochloride. |
|
| CAS NO |
: |
91296-86-5 |
|
| Molecular Formula |
: |
C21H20ClF2N3O3 |
|
| Molecular Weight |
: |
435.85 |
|
| Pharmacopoeia Compliance |
: |
Inhouse Standard |
|
| Description |
: |
Almost white to light yellow free flowing powder. |
|
| Shelf life |
: |
5 years |
|
|
|
|
|
|
| Active pharmaceutical Ingredients |
: |
Difloxacin Base |
|
| Chemical Name |
: |
6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-7-(4-methyl piperazin-1-yl)-4-oxoquinoline-3-carboxylic acid |
|
| CAS NO |
: |
98106-17-3 |
|
| Molecular Formula |
: |
C21H19F2N3O3 |
|
| Molecular Weight |
: |
399.40 |
|
| Pharmacopoeia Compliance |
: |
Inhouse Standard |
|
| Description |
: |
Almost white to light yellow free flowing powder. |
|
| Shelf life |
: |
5 years |
|
|
|
|
|
|
| Active pharmaceutical Ingredients |
: |
Ciprofloxacin Base |
|
| Chemical Name |
: |
Ciprofloxacin Base is 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(piperazin-1- yl)quinoline-3-carboxylic acid. |
|
| CAS NO |
: |
85721-33-1 |
|
| Molecular Formula |
: |
C17H18FN3O3 |
|
| Molecular Weight |
: |
331.35 |
|
| Pharmacopoeia Compliance |
: |
USP / IP / EP / BP |
|
| Description |
: |
Off White to Pale Yellow Crystalline powder |
|
| Shelf life |
: |
5 years |
|
|
|
|
| * Documentation support for US DMF / EDMF in CTD |
|
| * Products under patents are offered subject to the patent laws of the importing countries. The buyer is totally responsible for any Patent rights in a specific country. |
|
